endo, pharmaceutical, pain, pain management, endo pharmaceuticals holdings inc., pain relief, osteoarthritis, post-surgical pain, anesthesia, specialty, oncology, supportive care, neurology, anesthesiology, critical care, phn, compound, capsules, shingles, postherpetic neuralgia, neuropathic, neuralgia, herpes, zoster, acute pain, chronic pain, low-back pain, moderate-to-severe pain, chronogesic, allodynia, hyperalgesia, opioid , opiate, narcotic, analgesia, analgesic, patch, topical, plaster, oxymorphone, percocet, lidoderm, percodan, depomorphine, propofol, narcan, nubain, numorphan, zydone, hycodan, hycomine, hycotuss, moban, symmetrel, butalbital, codeine, endocet, endodan, hydromorphone, tablets, morphine sulfate, amantadine, hcl, syrup, carbidopa, levodopa, nitroglycerin, selegiline, chadds ford, pennsylvania, pa, emerging, patient, healthcare professionals, investor, company

endo pharmaceuticals has established leadership in pain management. we research, develop and market prescription pharmaceuticals used primarily to treat and manage pain and are expanding our presence in complementary therapeutic areas.